drug protocol number

TMP-0010230

drug sponsor

Astrazeneca

drug study

Anifrolumab

drug trial site

Aseer Central Hospital (Abha), International Medical Center (Jeddah),King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)

drug status

Ongoing

drug phase